FDA Approves First Tablet Created by 3D Printing: TUESDAY.
Experts tell you 3D printing of supplements could usher in an era where medicines can be custom-ordered, predicated on specific patient needs, rather than a ‘one-product-fits-all’ approach. ‘Going back 50 years we have manufactured tablets in factories and shipped them to hospitals and for the 1st time this procedure means we can produce tablets much nearer to the individual,’ Dr. Mohamed Albed Alhnan, a lecturer in pharmaceutics at the University of Central Lancashire in britain, explained in an interview with BBC Information. By making slight modifications to the software before printing, hospitals could adjust the dose for individual patients, he said.Today’s findings from the Atmosphere Trial echo data from other managed trials that demonstrated BT is normally safe and good for these sufferers in the first season after treatment. The data demonstrated that over five years: The % of sufferers reporting respiratory adverse occasions remained stableHospitalizations and er appointments for respiratory symptoms remained stablePulmonary function remained stable Zero incidences of pneumothorax, intubation, mechanical ventilation, cardiac arrhythmias or death as a result of BT treatment over the five year follow-upBT, which is the first device-structured asthma treatment authorized by the U.S.